Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a structured chat with a nurse boost medication adherence in IBD?

NCT ID NCT07652840

Disease control Sponsor: Izmir Katip Celebi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests whether a nurse-led education program, based on the Health Belief Model, can improve treatment adherence in people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who are receiving anti-TNF therapy. The program aims to address patients' concerns and barriers to taking their medication as prescribed. The study compares this structured education to the standard education usually given in clinics, measuring adherence and patient-nurse collaboration.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
structured patient education program
What this could lead to
If effective, this education program could help people with inflammatory bowel disease stick to their anti-TNF treatment, potentially improving disease control and quality of life.
What could go wrong
This is a relatively small, early-stage behavioral study. The results may not apply to all IBD patients or settings, and adherence improvements may not translate to long-term health benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

140 people

The number who actually took part.

Started

Feb 2024

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or older * Diagnosed with inflammatory bowel disease (Crohn's disease or ulcerative colitis) * Diagnosed with inflammatory bowel disease for at least 6 months * Receiving anti-TNF-α therapy for at least 3 months * Able to read and write in Turkish * Able to communicate effectively * Cognitively competent * Provided written informed consent and agreed to participate in the study Exclusion Criteria: * Presence of cognitive disorders that may impair understanding or decision-making (e.g., dementia, Alzheimer's disease) * History of malignant or premalignant disease * Use of more than four concurrent medications (e.g., medications for hypertension, diabetes, cancer, or hematologic diseases)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adherence, patient are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Crohn disease Health Behavior inflammatory bowel disease Medication Adherence Patient Compliance Patient Participation Treatment Adherence and Compliance ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adherence, patient Inflammatory bowel disease (Crohn's disease; ulcerative colitis) Structured education

Contacts and locations

Locations

  • Izmir Ekonomi University Medical Point Hospital

    Izmir, Turkey (Türkiye)

  • İzmir Atatürk Training and Research Hospital

    Izmir, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.